Home : About Medis : Our History

Our History

Service and product provider delivering results

We've come a long way since we started in 1985. Ever since the beginning, we have been a partner of choice for all the largest entities in the generic pharmaceutical industry, punching far above our weight every single day. We are very proud of our humble and small beginning, and at the same time we look forward to the future and what it brings.

1985
MEDIS FOUNDED

1994
CAPTOPRIL LAUNCH IN GERMANY

2000
ANNUAL SALES OF 20M EUR
First stand at CPhI

2001
TOTAL 1 BILLION UNITS SOLD
Medis - Isle of Man established
Biggest launch:
Ciprofloxacin - 41 million units
Launch info:
Lisinopril - 286 million units
Loratadine - 45 million units

2002
TOTAL 2 BILLION UNITS SOLD
Medis Germany founded. Total number of products is 20
Biggest launch:
Citalopram - 50 million units
New markets/no of customers:
20 Markets sold to in the year.  Sold to 54 Clients

2003
ANNUAL REVENUES OVER 100M EUR
Opening of Malta factory with Medis customer event.
Biggest launch:
Fluconazole - 1.5 million units

2004
DEDICATED LAUNCH COORDINATION DEPARTMENT ESTABLISHED
Biggest launch:
Ramipril Launch - 223 million units; UK / DE / DK (9 countries in total)
Launch info:
Lis HCT - 86 million units, launched from Malta
Quinapril HCT - 28 million units
New markets/no of customers:
36 markets sold to from beginning. 33 markets sold to in the year. Sold to 79 clients

2005
RAMIPRIL SOLD IN 17 COUNTRIES
Actavis Acquired Alpharma, Medis customer
Biggest launch:
Glimepride - 129 million units
Launch info:
Lamotrigine dispersible - 27 million units
New markets/no of customers:
Sold to 110 clients in 39 markets this year

2006
FIRST LAUNCH FROM INDIA; FINASTERIDE
Biggest launch:
Sumatriptan - 1.8 million units
New markets/no of customers:
54 markets sold to from beginning. 47 markets sold to in the year. Sold to 144 Clients.

2007
FRANCE OFFICE OPENS
Local presence in Dubai and Singapore
Biggest launch:
AOK in Germany
Launch info:
Olanzapine -12 million units
New markets/no of customers:
58 markets sold to from beginning. 44 markets sold to in the year. Sold to 161 clients

2008
TOTAL NUMBER OF SOLD UNITS REACHES 3BN
Gudbjorg Edda leaves Medis to take on a senior management role for Actavis. Valur Ragnarsson new CEO
Biggest launch:
Olanzapine orodispersible - 4.8 million units
Launch info:
Nebivolol - 19 million units
New markets/no of customers:
Sold to 178 clients in 43 markets this year

2009
SPAIN OFFICE ESTABLISHED
Local presence in Russia/CIS
Biggest launch:
Atorvastatin Magnesium - 70.8 million, launch in Spain
 
Launch info:
Clopidrogel Besylate - 64 million units
Gemcitabine freeze dried - 0.3 million units
Pantoprazole - 50 million units
New markets/no of customers:
60 markets sold to from beginning. 46 markets sold to in the year. Sold to 209 clients

2010
ANNUAL REVENUES OVER 200M EUR
Medis portfolio established. Product portfolio reaches 100 sold. Local presence in Italy.
Biggest launch:
Docetaxel solution (Novel) - 0.04 million units
New markets/no of customers:
62 markets sold to from beginning. 48 markets sold to in the year. Sold to 238 clients

2011
SOLD TO 248 CLIENTS/CUSTOMERS THIS YEAR
Biggest launch:
Repaglinide - 81 million units
New markets/no of customers:
67 markets sold to from beginning. 49 markets sold to in the year.
 
2012
MEDIS AND SPECIFAR COMBINE BUSINESSES
Biggest launch:
Riluzole - 3.8 million units
 
Launch info:
Esomeprazole - 13 million units
New markets/no of customers:
69 markets sold to from beginning. 52 markets sold to in the year. Sold to 266 clients

2013
ANNUAL SALES REACH OVER 300M USD
Medis PTY Australia founded
Biggest launch:
Telmisartan HCT - 37 million units
New markets/no of customers:
73 markets sold to from beginning. 58 markets sold to in the year. Sold to 258 clients

2014
1 BILLION UNITS SOLD IN FRANCE IN A SINGLE YEAR
New office in Paris, France. Office in Como, Italy opens. Over 100 employees for first time
Biggest launch:
Nicotine Replacement Therapy (NRT) - 27 million units
 
Launch info:
Budesonide solution - 15.4 million units
Levodopa/Carbidopa/Entacapone - 11.3 million units
Rosuvastatin - 22 million units
New markets/no of customers:
78 markets sold to from beginning. 61 markets sold to in the year. Sold to 266 clients. Total number of products is 238.

2015
30TH ANNIVERSARY OF MEDIS
Opens offices in Dubai, UAE, in Warsaw, Poland, and re-launching presence in Brazil

Go Back Send Print